logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Zus Health Closes Financing, Signs Partnership With Elation Health, To Accelerate Growth Of Its Data Service To Provide Connective Tissue For Healthcare

Mar 16, 2023almost 3 years ago
BostonHealthcare

Investors

Andreessen HorowitzMaverick VenturesF Prime CapitalJazz Venture Partners

Description

Zus Health, (pronounced "Zoose"), a next-generation shared health data platform bringing distributed patient data directly to the point of care, announced today that the company has closed a $40 million financing. Investors include JAZZ Venture Partners, F-Prime Capital, Maverick Ventures, and Andreessen Horowitz (a16z). Zus will use this funding to continue growing its platform with additional unique data sources, workflow and referral solutions, and integration pathways to empower healthcare providers to leverage external patient data in their care and collaborate around a shared patient record.

Company Information

Company

Zus Health

Location

1 Lincoln Street, Floor 24

Boston, Massachusetts, United States

About

Zus Health is a shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data at the point of care via API, embedded components, and direct EHR integrations. Founded in 2020 by Jonathan Bush, co-founder and former CEO of athenahealth, Zus partners with HIEs and other data networks to aggregate patient clinical history and then translates that history into user-friendly information at the point of care. Their networks provide access to data across 70K+ provider sites and 270M+ patients. Zus's mission is to catalyze healthcare's greatest innovators by maximizing the value of patient insights - so that they can build up, not around. To learn more, visit www.zushealth.com.

Related People

5 contacts

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers